Suppr超能文献

Are There Neurological Symptoms in Type 1 of Gaucher Disease?

作者信息

Alaei Mohammadreza, Jafari Narjes, Rohani Farzaneh, Ahmadabadi Farzad, Azadi Rezvan

机构信息

Department of Pediatric Endocrinology, Faculty of Medicine, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.

Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Child Neurol. 2018 Spring;12(2):99-106.

Abstract

OBJECTIVE

Gaucher disease (GD) is a rare inborn error of metabolism, classified as a lipid storage disorders. This disease is caused by a deficiency in glucocerebrosidase enzyme. It has been classified according to the presence or absence of neurological symptoms into the following types: type 1 non-neuropathic, type 2 acute infantile neuropathic and type 3 or chronic neuropathic. We evaluated neurological symptoms in patients with GD1 and GD3 and compared both of these groups.

MATERIALS & METHODS: Eleven patients were identified according to their clinical presentation and the presence of disease confirmed by genetic testing, from 2006-2016, at the Mofid Children Hospital Clinic, Tehran, Iran. We included eight patients with GD 1 and three patients with GD3. Careful neurological examination was performed on these patients during treatment by pediatric neurologist.

RESULTS

Patients with GD1 had some neurological symptoms including cognitive impairment, developmental disability, behavioral disorder, microcephaly and increased deep tendon reflexes (DTR). Of course, neurological signs in patients with type 3 of GD were different and were included seizures, supranuclear gaze palsy, cerebellar signs, and ataxia.

CONCLUSION

The current nomenclature for 3 types of Gaucher disease does not meet all clinical symptoms. Patients with GD1 display many neurological deficits in young ages not reported adequately earlier.

摘要

相似文献

1
Are There Neurological Symptoms in Type 1 of Gaucher Disease?
Iran J Child Neurol. 2018 Spring;12(2):99-106.
2
Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients.
Blood Cells Mol Dis. 2018 Feb;68:86-92. doi: 10.1016/j.bcmd.2016.10.011. Epub 2016 Oct 21.
6
Neurological symptoms in adults with Gaucher disease: a systematic review.
J Neurol. 2024 Jul;271(7):3897-3907. doi: 10.1007/s00415-024-12439-5. Epub 2024 May 21.
7
Ocular motor abnormalities in Gaucher disease.
Neuropediatrics. 1999 Dec;30(6):289-93. doi: 10.1055/s-2007-973507.
8
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG).
J Inherit Metab Dis. 2010 Aug;33(4):331-8. doi: 10.1007/s10545-010-9095-5. Epub 2010 Jun 2.
9
Gaucher disease and its treatment options.
Ann Pharmacother. 2013 Sep;47(9):1182-93. doi: 10.1177/1060028013500469.
10
The role of neurogenetics in Gaucher disease.
Arch Neurol. 1993 Nov;50(11):1212-24. doi: 10.1001/archneur.1993.00540110088009.

引用本文的文献

1
A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment.
Acta Neurol Belg. 2024 Aug;124(4):1213-1223. doi: 10.1007/s13760-024-02493-1. Epub 2024 Feb 28.
2
Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish.
Int J Mol Sci. 2023 Mar 1;24(5):4747. doi: 10.3390/ijms24054747.
3
Gaucher disease - more than just a rare lipid storage disease.
J Mol Med (Berl). 2022 Apr;100(4):499-518. doi: 10.1007/s00109-021-02174-z. Epub 2022 Jan 23.

本文引用的文献

1
Clinical manifestations and management of Gaucher disease.
Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):157-64. doi: 10.11138/ccmbm/2015.12.2.157. Epub 2015 Oct 26.
3
Central ocular motor disorders, including gaze palsy and nystagmus.
J Neurol. 2014 Sep;261 Suppl 2(Suppl 2):S542-58. doi: 10.1007/s00415-014-7385-9.
4
Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients.
Mol Genet Metab. 2014 Nov;113(3):213-8. doi: 10.1016/j.ymgme.2014.07.022. Epub 2014 Aug 4.
5
Outcome of early-treated type III Gaucher disease patients.
Blood Cells Mol Dis. 2014 Sep;53(3):105-9. doi: 10.1016/j.bcmd.2014.05.007. Epub 2014 Jun 28.
6
Gaucher disease and other storage disorders.
Hematology Am Soc Hematol Educ Program. 2012;2012:13-8. doi: 10.1182/asheducation-2012.1.13.
7
Hyposmia and cognitive impairment in Gaucher disease patients and carriers.
Mov Disord. 2012 Apr;27(4):526-32. doi: 10.1002/mds.24945. Epub 2012 Feb 16.
8
[Cerebellar syndrome in Gaucher's disease].
Nervenarzt. 2009 Oct;80(10):1216-8. doi: 10.1007/s00115-009-2795-0.
9
Neurological evaluation of patients with Gaucher disease diagnosed as type 1.
J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):219-22. doi: 10.1136/jnnp.2006.111518. Epub 2007 Aug 6.
10
[Neurological manifestations of type 1 Gaucher's disease: Is a revision of disease classification needed?].
Rev Neurol (Paris). 2006 Nov;162(11):1076-83. doi: 10.1016/s0035-3787(06)75120-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验